Bleeding Risk With Combination Intrapleural Fibrinolytic and Enzyme Therapy in Pleural Infection: An International, Multicenter, Retrospective Cohort Study.

Chest · 2022 · PMC9773231 · PMID 35716828

Europe PMC DOI

hedged sentence

0.4800

closest p · 9.6× alpha

0.4800

boldest claim

The sentences

did not reach statistical significanceP = .48not close (p > 0.1)

In those patients in whom anticoagulation was continued, the MIST-2 dosing strategy was associated with a bleeding incidence of 16 of 165 patients (9.7%) compared with 2 of 32 patients (6.3%) when using a dose-reduction strategy, but this did not reach statistical significance ( P = .48).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.